What is the price-to-earnings ratio of Insulet?
The price-earnings ratio of Insulet is currently 7.98.
Insulet P/S 2025
Insulet P/S
7.98
Ticker
PODD
ISIN
US45784P1012
WKN
A0MQX8
As of Jan 8, 2025, Insulet's P/S ratio stood at 7.98, a 25.27% change from the 6.37 P/S ratio recorded in the previous year.
The Insulet P/S history
Insulet Aktienanalyse
What does Insulet do?
Insulet Corp is an American company that was founded in 2000 and is headquartered in Acton, Massachusetts. Its goal is to improve the quality of life for people with diabetes by developing innovative products that make living with this chronic disease easier. Insulet Corp is known for its product "OmniPod." The OmniPod is a wireless, portable disposable insulin pump system that offers an alternative option to traditional pumping and insulin delivery systems. The OmniPod system consists of two small devices: a pod worn on the skin and a PDM (Personal Diabetes Manager) that regulates insulin delivery. The pod contains an insulin reservoir that communicates wirelessly with the PDM. The insulin dose is administered directly into the body without needles or tubes. Insulet Corp is also introducing the "OmniPod DASH System." This new system combines the proven design of the OmniPod pod with a new color touchscreen handheld device that allows for even easier operation. The DASH system also offers the ability to control insulin dosing from a smartphone, which can be taken with diabetics wherever they go. The success of the OmniPod system has made Insulet Corp a leading company in the diabetes industry. The company has also developed and introduced products and services in other areas of diabetes treatment. Insulet Corp has developed another product called "Amigo." This product is a personalized travel and training program for people who require insulin. Amigo offers specialized and personalized training to support diabetics in managing complex situations. It also offers diet and exercise plans to make living with diabetes easier. Insulet Corp has also developed a software called "OmniPod Horizon." This software is a closed-loop system that automatically adjusts insulin dosing to keep blood sugar levels within the target range. The system is currently in the development phase and is expected to be released in 2020. Insulet Corp has also developed a program called the "OmniPod Partner Program," which targets doctors and pharmacists. The program provides training and educational materials for healthcare providers to help them better treat and manage their patients. Since 2009, Insulet Corp has been listed on the NASDAQ stock exchange and has continuously evolved since then. The company currently has over 1500 employees and operates in North America, Europe, and the Middle East. Insulet Corp is a company focused on the development of innovative, life-changing products and services. It is expected to continue to play a significant role in improving the quality of life for people with diabetes in the future. Insulet ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Insulet's P/S Ratio
Insulet's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Insulet's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Insulet's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Insulet’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Insulet stock
How has the price-earnings ratio of Insulet changed compared to last year?
The price-to-earnings ratio of Insulet has increased by 25.27% increased compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Insulet high compared to other companies?
Yes, the price-to-earnings ratio of Insulet is high compared to other companies.
How does an increase in the price-earnings ratio of Insulet affect the company?
An increase in the price-earnings ratio of Insulet would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Insulet affect the company?
A decrease in the price-earnings ratio of Insulet would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Insulet?
Some factors that influence the price-earnings ratio of Insulet are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Insulet pay?
Over the past 12 months, Insulet paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Insulet is expected to pay a dividend of 0 USD.
What is the dividend yield of Insulet?
The current dividend yield of Insulet is .
When does Insulet pay dividends?
Insulet pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Insulet?
Insulet paid dividends every year for the past 0 years.
What is the dividend of Insulet?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Insulet located?
Insulet is assigned to the 'Health' sector.
Wann musste ich die Aktien von Insulet kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Insulet from 1/8/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/8/2025.
When did Insulet pay the last dividend?
The last dividend was paid out on 1/8/2025.
What was the dividend of Insulet in the year 2024?
In the year 2024, Insulet distributed 0 USD as dividends.
In which currency does Insulet pay out the dividend?
The dividends of Insulet are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Insulet stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Insulet
Our stock analysis for Insulet Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Insulet Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
